A detailed history of Los Angeles Capital Management LLC transactions in Axonics, Inc. stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 4,089 shares of AXNX stock, worth $290,237. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,089
Previous 4,139 1.21%
Holding current value
$290,237
Previous $278,000 2.16%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$67.3 - $69.67 $3,365 - $3,483
-50 Reduced 1.21%
4,089 $284,000
Q1 2024

Apr 05, 2024

BUY
$56.67 - $69.36 $234,557 - $287,081
4,139 New
4,139 $285,000
Q2 2023

Aug 03, 2023

BUY
$47.99 - $60.21 $565,658 - $709,695
11,787 New
11,787 $594,000

Others Institutions Holding AXNX

About Axonics, Inc.


  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.49B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track Los Angeles Capital Management LLC Portfolio

Follow Los Angeles Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Los Angeles Capital Management LLC with notifications on news.